Tibet Rhodiola Pharmaceutical Holding Co Cash Flow Conversion Efficiency

Latest as of December 2025: 0.072x

Tibet Rhodiola Pharmaceutical Holding Co cash flow conversion efficiency. Based on the latest financial reports, Tibet Rhodiola Pharmaceutical Holding Co (600211) has a cash flow conversion efficiency ratio of 0.072x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥297.86 Million ≈ $43.59 Million USD) by net assets (CN¥4.17 Billion ≈ $609.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)

Cash flow conversion efficiency of Tibet Rhodiola Pharmaceutical Holding Co from 1999 to 2025. This chart illustrates how Tibet Rhodiola Pharmaceutical Holding Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Tibet Rhodiola Pharmaceutical Holding Co stock quote for real-time trading data and today's change.

Tibet Rhodiola Pharmaceutical Holding Co Cash Flow Conversion Ratio Explained

Tibet Rhodiola Pharmaceutical Holding Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tibet Rhodiola Pharmaceutical Holding Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tibet Rhodiola Pharmaceutical Holding Co ranked by their cash flow conversion efficiency. Also see Tibet Rhodiola Pharmaceutical Holding Co stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Newmark Group Inc NASDAQ:NMRK	0.207x
Per Aarsleff Holding A/S CO:PAAL-B	0.028x
KEPCO Engineering & Construction KO:052690	-0.010x
Southchip Semiconductor Technology (Shanghai) Co. Ltd. A SHG:688484	-0.024x
Intapp Inc NASDAQ:INTA	0.028x
Sinomag Technology Co Ltd SHE:300835	0.011x
Alpha Metallurgical Resources Inc NYSE:AMR	0.032x
Stock Yards Bancorp Inc NASDAQ:SYBT	0.051x

Annual Cash Flow Conversion Efficiency for Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)

The table below shows the annual cash flow conversion efficiency of Tibet Rhodiola Pharmaceutical Holding Co from 1999 to 2025. Review Tibet Rhodiola Pharmaceutical Holding Co free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥4.17 Billion ≈ $609.56 Million	CN¥1.03 Billion ≈ $150.24 Million	0.246x	-2.08%
2024-12-31	CN¥3.95 Billion ≈ $578.32 Million	CN¥994.79 Million ≈ $145.57 Million	0.252x	-21.53%
2023-12-31	CN¥3.37 Billion ≈ $493.67 Million	CN¥1.08 Billion ≈ $158.35 Million	0.321x	+16.10%
2022-12-31	CN¥3.03 Billion ≈ $443.50 Million	CN¥837.38 Million ≈ $122.53 Million	0.276x	+99.38%
2021-12-31	CN¥2.65 Billion ≈ $387.05 Million	CN¥366.53 Million ≈ $53.64 Million	0.139x	-16.23%
2020-12-31	CN¥2.59 Billion ≈ $378.76 Million	CN¥428.17 Million ≈ $62.65 Million	0.165x	-17.33%
2019-12-31	CN¥2.45 Billion ≈ $358.04 Million	CN¥489.59 Million ≈ $71.64 Million	0.200x	+56.16%
2018-12-31	CN¥2.26 Billion ≈ $330.29 Million	CN¥289.22 Million ≈ $42.32 Million	0.128x	+186.57%
2017-12-31	CN¥2.05 Billion ≈ $299.31 Million	CN¥91.46 Million ≈ $13.38 Million	0.045x	-88.24%
2016-12-31	CN¥658.19 Million ≈ $96.31 Million	CN¥250.21 Million ≈ $36.61 Million	0.380x	+37.92%
2015-12-31	CN¥485.90 Million ≈ $71.10 Million	CN¥133.93 Million ≈ $19.60 Million	0.276x	+180.74%
2014-12-31	CN¥414.18 Million ≈ $60.61 Million	CN¥-141.40 Million ≈ $-20.69 Million	-0.341x	-148.81%
2013-12-31	CN¥399.20 Million ≈ $58.42 Million	CN¥279.22 Million ≈ $40.86 Million	0.699x	+379.69%
2012-12-31	CN¥385.44 Million ≈ $56.40 Million	CN¥56.20 Million ≈ $8.22 Million	0.146x	+328.05%
2011-12-31	CN¥354.94 Million ≈ $51.94 Million	CN¥12.09 Million ≈ $1.77 Million	0.034x	+481.16%
2010-12-31	CN¥324.19 Million ≈ $47.44 Million	CN¥1.90 Million ≈ $278.05K	0.006x	-90.17%
2009-12-31	CN¥300.00 Million ≈ $43.90 Million	CN¥17.88 Million ≈ $2.62 Million	0.060x	-22.44%
2008-12-31	CN¥279.15 Million ≈ $40.85 Million	CN¥21.46 Million ≈ $3.14 Million	0.077x	+215.24%
2007-12-31	CN¥274.28 Million ≈ $40.14 Million	CN¥-18.30 Million ≈ $-2.68 Million	-0.067x	-178.61%
2006-12-31	CN¥396.34 Million ≈ $58.00 Million	CN¥33.63 Million ≈ $4.92 Million	0.085x	+76.37%
2005-12-31	CN¥393.25 Million ≈ $57.54 Million	CN¥18.92 Million ≈ $2.77 Million	0.048x	-22.12%
2004-12-31	CN¥435.51 Million ≈ $63.73 Million	CN¥26.90 Million ≈ $3.94 Million	0.062x	-44.44%
2003-12-31	CN¥424.53 Million ≈ $62.12 Million	CN¥47.20 Million ≈ $6.91 Million	0.111x	+41.76%
2002-12-31	CN¥418.85 Million ≈ $61.29 Million	CN¥32.85 Million ≈ $4.81 Million	0.078x	+106.06%
2001-12-31	CN¥406.50 Million ≈ $59.48 Million	CN¥15.47 Million ≈ $2.26 Million	0.038x	-25.49%
2000-12-31	CN¥402.35 Million ≈ $58.88 Million	CN¥20.55 Million ≈ $3.01 Million	0.051x	+786.04%
1999-12-31	CN¥389.71 Million ≈ $57.03 Million	CN¥2.25 Million ≈ $328.81K	0.006x	--

About Tibet Rhodiola Pharmaceutical Holding Co

SHG:600211 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.90 Billion

CN¥13.01 Billion CNY

Market Cap Rank

#6110 Global

#1155 in China

Share Price

CN¥40.37

Change (1 day)

-1.13%

52-Week Range

CN¥35.31 - CN¥47.72

All Time High

CN¥165.99